Authors: Schilling, T Burck, J Sinn, HP Clemens, A Otto, HF Hoppner, W Herfarth, C Ziegler, R Schwab, M Raue, F

Citation: T. Schilling et al., Prognostic value of codon 918 (ATG -> ACG) RET proto-oncogene mutations insporadic medullary thyroid carcinoma, INT J CANC, 95(1), 2001, pp. 62-66

Authors: Kloehn, S Otte, C Korsanke, M Arendt, T Clemens, A Glasow, A Bornstein, SR Folsch, UR Monig, H

Citation: S. Kloehn et al., Expression and distribution of the prolactin receptor in normal rat liver and in experimental liver cirrhosis, HORMONE MET, 33(7), 2001, pp. 394-401

Authors: Luttges, J Reinecke-Luthge, A Mollmann, B Menke, MAOH Clemens, A Klimpfinger, M Sipos, B Kloppel, G

Citation: J. Luttges et al., Duct changes and K-ras mutations in the disease-free pancreas: analysis oftype, age relation and spatial distribution, VIRCHOWS AR, 435(5), 1999, pp. 461-468

Authors: Clemens, A Klevesath, MS Hofmann, M Raulf, F Henkels, M Amiral, J Seibel, MJ Zimmermann, J Ziegler, R Wahl, P Nawroth, PP

Citation: A. Clemens et al., Octreotide (somatostatin analog) treatment reduces endothelial cell dysfunction in patients with diabetes mellitus, METABOLISM, 48(10), 1999, pp. 1236-1240

Authors: Clemens, A Rademaekers, A Specht, C Kolsch, E

Citation: A. Clemens et al., The J558 V-H CDR3 region contributes little to antibody avidity; however, it is the recognition element for cognate T cell control of the alpha(1 -> 3) dextran-specific antibody response, INT IMMUNOL, 10(12), 1998, pp. 1931-1942